Altratech Team

We are a team of twenty scientists and engineers working together since 2016 (molecular biology, surface chemistry, microfluidics, and chip design) to bring together nano biotechnology, chemistry, and semiconductors to radically change the accessibility of high content genetic data.

Based on the novel Detection by Proxy concept, Altratech has developed the next generation of molecular detection. The technology enables any person, anywhere, to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples.

Dr. Tara Dalton


Dr. David McGuire


Dr. Brian O’Farrell


Tim Cummins


Dr. Moira McCarthy

R&D Manager

Niall Olden

Chairman (Investor)
Kernel Capital

Cyril McGuire

(Director & Investor)
Infinity Capital